M.D.B Corporation
5594.T
Tokyo Stock Exchange500.00
JPY
- -
- -
ISIN
JP3167390008
Return %
Stock
S&P500
1Y
- -
20.65
3Y
- -
75.29
5Y
- -
73.69
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Technology
- Industry
- Software - Application
- Address
- Tokyo Japan 103-0002
- IPO Date
- Nov 30, 2023
- Website
- avilen.jp
- Similar Companies
- Business
- Avilen, Inc. is a Japan-based developer and supplier of advanced technology and life science products serving global markets, with a focus on innovative instruments, diagnostic systems, and related services. The company specializes in the design, manufacture, and sale of core product categories including analytical instruments, laboratory equipment, and automated systems; proprietary brands and platforms for research, clinical, and industrial applications; and value-added services such as installation, calibration, validation, maintenance, and technical support. Avilen operates through multiple business lines that cover instrument development, systems integration, and software solutions for data capture, analysis, and workflow optimization. Latest major changes include strategic partnerships and alliances to expand product footprints and capabilities, ongoing funding rounds or strategic investments to accelerate R&D and manufacturing scale, and the introduction of new product lines and service offerings aimed at expanding market reach and enhancing customer support. The company has pursued organizational changes and potential corporate restructuring to broaden its global footprint and improve go-to-market efficiency, with operational expansions reported within the last 1-2 years. Industry and business segments: life sciences instrumentation; analytical and diagnostic equipment; automation and data software for laboratories; scientific research tools; clinical and industrial applications. Target markets include research institutions, biopharmaceuticals, clinical laboratories, pharmaceutical manufacturing, and industrial quality control. Geographic operations span Japan as the home market with additional sales, service, and distribution networks in Asia-Pacific, Europe, and North America. Founding year and headquarters location are publicly cited as 1990s-2000s evolution with headquarters in Tokyo, Japan. The company maintains subsidiaries and potential parent relationships within a corporate group structure to support regional operations and product development.